Group One Trading
XBIT icon

Group One Trading’s XBiotech XBIT Stock Holding History

Group One Trading’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.58K Buy
+2,800
New +$6.77K ﹤0.01% 6585
2025
Q1 		– Sell
-11,600
Closed -$45.8K – 8473
2024
Q4 		$45.8K Buy
+11,600
New +$79.1K ﹤0.01% 5119
2022
Q3 		– Sell
-4,000
Closed -$23K – 8348
2022
Q2 		$23K Buy
+4,000
New +$26.9K ﹤0.01% 6198
2021
Q4 		– Sell
-500
Closed -$6K – 8936
2021
Q3 		$6K Sell
500
-7,000
-93% -$112K ﹤0.01% 7700
2021
Q2 		$124K Buy
7,500
+1,500
+25% +$25.4K ﹤0.01% 5742
2021
Q1 		$103K Buy
6,000
+5,000
+500% +$93.3K ﹤0.01% 5637
2020
Q4 		$16K Sell
1,000
-67,200
-99% -$1.24M ﹤0.01% 5626
2020
Q3 		$1.3M Buy
68,200
+4,500
+7% +$77.7K ﹤0.01% 1952
2020
Q2 		$873K Sell
63,700
-5,400
-8% -$75.9K ﹤0.01% 2157
2020
Q1 		$734K Buy
69,100
+57,700
+506% +$939K 0.01% 1771
2019
Q4 		$213K Sell
11,400
-23,600
-67% -$304K ﹤0.01% 3126
2019
Q3 		$366K Buy
35,000
+1,000
+3% +$8.14K ﹤0.01% 2606
2019
Q2 		$258K Buy
34,000
+2,900
+9% +$25.2K ﹤0.01% 2665
2019
Q1 		$343K Buy
31,100
+5,300
+21% +$43K ﹤0.01% 2255
2018
Q4 		$131K Sell
25,800
-18,200
-41% -$74.7K ﹤0.01% 2998
2018
Q3 		$140K Buy
44,000
+7,200
+20% +$28K ﹤0.01% 3276
2018
Q2 		$165K Buy
36,800
+3,200
+10% +$14.5K ﹤0.01% 3199
2018
Q1 		$180K Sell
33,600
-3,900
-10% -$18K ﹤0.01% 2866
2017
Q4 		$148K Sell
37,500
-37,500
-50% -$158K ﹤0.01% 3121
2017
Q3 		$328K Buy
75,000
+61,100
+440% +$289K ﹤0.01% 2393
2017
Q2 		$65K Buy
13,900
+5,200
+60% +$49.8K ﹤0.01% 3370
2017
Q1 		$143K Buy
8,700
+4,800
+123% +$62.8K ﹤0.01% 2756
2016
Q4 		$39K Buy
3,900
+2,300
+144% +$30.6K ﹤0.01% 3399
2016
Q3 		$22K Buy
+1,600
New +$23.5K ﹤0.01% 3745

Other funds holding XBIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Group One Trading's XBIT Position: Q1 2025 in Review

Group One Trading sold out of XBiotech (XBIT) in Q1 2025, closing a stake of 7,500 shares — an estimated $29.6K sold.

Group One Trading first reported a position in XBIT in Q3 2016 and held it in 24 quarters. The position peaked at $474K in Q3 2020. 55 funds tracked by Wall St. Rank hold XBIT as of Q1 2025.

  • Group One Trading reported no remaining XBiotech position as of Q1 2025 after selling out during the quarter.
  • Group One Trading sold 7,500 XBiotech shares in Q1 2025, an estimated $29.6K.
  • Group One Trading first reported a position in XBiotech in Q3 2016 and held it in 24 quarters.
  • Group One Trading's XBiotech position peaked at $474K in Q3 2020.
  • 55 funds tracked by Wall St. Rank held XBiotech as of Q1 2025.

Based on Group One Trading's 13F filing for Q1 2025, filed 14 May 2025.